Pan-cancer analysis identifies KPNA7 as a prognostic and immune-related biomarker with functional relevance in gastric cancer.
7 affiliations
- 1The First Clinical Medical College, Lanzhou University, Lanzhou, 730000, China.
- 2Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, 730000, China.
- 3Gansu Province Clinical Research Center for Digestive Diseases, The First Hospital of Lanzhou University, Lanzhou, 730000, China.
- 4Department of Nephrology, The First Hospital of Lanzhou University, Lanzhou, 730000, China.
- 5Department of Endocrinology, The First Hospital of Lanzhou University, Lanzhou, 730000, China. [email protected].
- 6Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, 730000, China. [email protected].
- 7Gansu Province Clinical Research Center for Digestive Diseases, The First Hospital of Lanzhou University, Lanzhou, 730000, China. [email protected].
Abstract
Background
KPNA7 modulated cellular functions via RNA interaction and had a crucial part in post-transcriptional gene expression regulation. However, the potential function played by KPNA7 in pan-cancer remained unclear.Methods
The Cancer Genome Atlas (TCGA) was performed to study the expression of KPNA7 in normal and cancer tissues. Kaplan-Meier survival analysis and spearman correlation analysis were used to evaluate the associations of KPNA7 expression with prognosis, immune cell infiltration, tumor mutational burden (TMB) and microsatellite instability (MSI). We further investigated the relationship between KPNA7 expression levels and sensitivity to anticancer drugs. Finally, the effects of KPNA7 on gastric cancer cell proliferation, clonogenicity, migration, invasion, apoptosis, cell cycle, and in vivo tumor growth were evaluated using CCK-8, colony formation, scratch, transwell, flow cytometry, and subcutaneous xenograft assays.Results
Bioinformatic analyses showed that KPNA7 was overexpressed in multiple tumors and was associated with unfavorable survival in selected cancer types. KPNA7 expression was significantly correlated with immune-related features, including immune cell infiltration, immunomodulatory factors, TMB, and MSI in several cancers. In addition, KPNA7 expression was associated with anticancer drug sensitivity patterns. Functional experiments further showed that KPNA7 knockdown inhibited the proliferation, migration, and invasion of gastric cancer cells while promoting apoptosis.Conclusion
These findings suggested that KPNA7 may serve as a potential biomarker with tumor-type-specific prognostic and immune-related relevance in cancer, providing new insights into its possible value in cancer biology and therapeutic stratification.
Related
- Pan-Cancer Analysis Identifies LUC7L2 as a Prognostic Biomarker and Potential Functional Regulator of Prostate Cancer Progression
- Multi-omics integration identifies PON2 as a prognostic biomarker and mediator of tumor microenvironment remodeling in gallbladder cancer
- Pan-cancer analysis identifies ANGPT4 as a potential prognostic biomarker associated with the tumor microenvironment in kidney renal clear cell carcinoma
- Comprehensive Pan-Cancer Bioinformatics Analysis Identifies DHX58 as a Promising Therapeutic Target and Prognostic Biomarker Across Multiple Tumor Types
- CHCHD2 as a prognostic biomarker and therapeutic target in lung adenocarcinoma: Insights from pan-cancer multi-omics and functional studies
BibTeX
@article{chen2026pancancer,
title = {{Pan-cancer analysis identifies KPNA7 as a prognostic and immune-related biomarker with functional relevance in gastric cancer.}},
author = {Xia Chen and Ailin Yue and Hui Wei and Huiyun Zhang and Weiming Sun and Yuping Wang},
journal = {BMC cancer},
year = {2026},
month = jul,
doi = {10.1186/s12885-026-16456-7},
url = {https://europepmc.org/article/MED/42902211},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Pan-cancer analysis identifies KPNA7 as a prognostic and immune-related biomarker with functional relevance in gastric cancer.
AU - Xia Chen
AU - Ailin Yue
AU - Hui Wei
AU - Huiyun Zhang
AU - Weiming Sun
AU - Yuping Wang
PY - 2026
DA - 2026/07/01
JO - BMC cancer
DO - 10.1186/s12885-026-16456-7
UR - https://europepmc.org/article/MED/42902211
AB - Background KPNA7 modulated cellular functions via RNA interaction and had a crucial part in post-transcriptional gene expression regulation. However, the potential function played by KPNA7 in pan-cancer remained unclear.Methods The Cancer Genome Atlas (TCGA) was performed to study the expression of KPNA7 in normal and cancer tissues. Kaplan-Meier survival analysis and spearman correlation analysis were used to evaluate the associations of KPNA7 expression with prognosis, immune cell infiltration, tumor mutational burden (TMB) and microsatellite instability (MSI). We further investigated the relationship between KPNA7 expression levels and sensitivity to anticancer drugs. Finally, the effects of KPNA7 on gastric cancer cell proliferation, clonogenicity, migration, invasion, apoptosis, cell cycle, and in vivo tumor growth were evaluated using CCK-8, colony formation, scratch, transwell, flow cytometry, and subcutaneous xenograft assays.Results Bioinformatic analyses showed that KPNA7 was overexpressed in multiple tumors and was associated with unfavorable survival in selected cancer types. KPNA7 expression was significantly correlated with immune-related features, including immune cell infiltration, immunomodulatory factors, TMB, and MSI in several cancers. In addition, KPNA7 expression was associated with anticancer drug sensitivity patterns. Functional experiments further showed that KPNA7 knockdown inhibited the proliferation, migration, and invasion of gastric cancer cells while promoting apoptosis.Conclusion These findings suggested that KPNA7 may serve as a potential biomarker with tumor-type-specific prognostic and immune-related relevance in cancer, providing new insights into its possible value in cancer biology and therapeutic stratification.
SN - 1471-2407
ER -